BRaIN Program Seminar Series Winter 2022
IDIGH Program Seminar Series Winter 2022
Wednesdays, 12 to 1 p.m.
Nature Communications study has implications for treatment of patients and genetic counselling
Jean-Jacques Lebrun and his team have discovered a promising treatment for triple negative breast cancer
New RI-MUHC study shows that health systems and unemployment influence...
Three key factors might offer 90% accuracy in predicting wide range of psychiatric disorders
Thursdays, 4 to 5 p.m.
MeDiC Program Seminar Series Winter 2022
Projects will mitigate impacts of the COVID-19 pandemic on children, youth and families and promote vaccine confidence
BMO gift will help cancer researchers at the RI-MUHC develop the hospital’s precision oncology program
New Adaptive Reconfiguration Index has crucial implications for clinical management and decision-making in unconscious and unresponsive...
The new Quebec SmartCare Consortium has received $10M to break down data silos and increase the...
For the first time, researchers link mutations in the FANCI gene to the risk of developing ovarian cancer
Doctoral student develops world's first non-invasive blood screening test for uveal melanoma
Work by RI-MUHC postdoc Angela Karellis published in The Lancet...
Pan-Canadian team receives financing to develop a national pediatric diabetes registry
Wednesdays, 4 to 5 p.m.
CORE Seminar Series Winter 2022
Recruitment of first U.S.-based patients in dapsone trial has started
CHHD Program Seminar Series Winter 2022
Mondays, 12 to 1 p.m.
Thanks to the Weston Family Foundation, the CLSA will employ MRI imaging and microbiome analyses to investigate cognitive aging
Congratulations to RI-MUHC trainee Motahareh Vameghestahbanati!
RI-MUHC scientist receives international acclaim for research that benefits pulmonary arterial hypertension patients
— 25 Items per Page